Silver Book reference

Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE

1 Matching Fact

Search matching Facts:
No results to display
    • Anti-VEGF Letter Improvement
      An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.